NCT03547518
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- William Beaumont Hospitals Royal Oak, Michigan, United States
Clinical trial condition
Urologic Diseases
Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.
13,827 public trials
2,184 recruiting studies
Urologic Diseases trial results
NCT03473782
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- New York University School of Medicine New York, United States
NCT04275297
- Conditions
- Bladder Pain Syndrome, Bronchial Diseases, Bronchiolitis, +35 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Completed
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
NCT02756637
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT04971057
- Conditions
- Anxiety, Anxiety Disorders, Female Urogenital Diseases, +13 more
- Locations
-
- Chang Gung Memorial Hospital at Linkou Taoyuan, Taiwan
NCT05527639
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
- Locations
-
- Charles Darwin University Darwin, Northern Territory, Australia
Completed
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT00471432
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +49 more
- Locations
-
Not specified
NCT00075660
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
Completed
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT02855203
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT03602079
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
- Locations
-
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Clinical Research Alliance, Inc. Lake Success, New York, United States